Tag: Vaccines
Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s
Thirty percent of those aged 60 years or older receiving booster reported at least one AE; few sought medical attention
Physician’s Briefing Weekly Coronavirus Roundup
Overall Risk of Myopericarditis Low After COVID-19 Vaccine
Overall incidence of myopericarditis does not differ significantly for those receiving COVID-19 vaccines versus non-COVID-19 vaccines
COVID-19 Vaccine Largely Protects Cancer Patients
However, higher risk seen for breakthrough infections and severe outcomes, especially for hematologic malignancies
Physician’s Briefing Weekly Coronavirus Roundup
Vaccination Mandate for Federal Workers Reinstated by Appeals Court
Mandate was introduced in September but enforcement was halted in January by a preliminary injunction issued by a federal judge in Texas
Fourth Dose of BNT162b2 Offers Protection Against Severe COVID-19
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose; protection against infection waned
FDA Advisers Weigh COVID-19 Booster Shots for Fall
Vaccine experts still guessing at what the ever-changing pandemic will bring
Cardiac Complications Up After SARS-CoV-2 Infection Versus Vaccines
Incidence of cardiac outcomes after mRNA COVID-19 vaccination highest in males aged 12 to 17 years, but risk 1.8 to 5.6 times higher after infection
Vaccination Offers Extra Protection After SARS-CoV-2 Infection
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination
